Showing results (151-160 of 322) with videos related to

Sort By:
Pageof 33
Biorxiv : the Preprint Server for Biology|March 27, 2026
An epigenetic bifunctional that toggles between transactivation and repressionAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
Blood|June 10, 2025
An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesisJustin Loke, Peter Geon Kim, Thuy T P Nguyen, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Discovery of electrophilic degraders that exploit SNAr chemistryZhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, et al.
Nature|June 10, 2005
MicroRNA expression profiles classify human cancersJun Lu, Gad Getz, Eric A Miska, et al.
Blood|January 6, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 diseaseRoman Schimmer, Nancy Klemm, Jonas Fullin, et al.
Blood|August 2, 2018
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in miceEmma C Fink, Marie McConkey, Dylan N Adams, et al.
Blood Advances|January 4, 2018
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cellsMia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, et al.
Science (New York, N.Y.)|December 3, 2013
Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cellsJan Krönke, Namrata D Udeshi, Anupama Narla, et al.
American Journal of Hematology|December 6, 2019
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapyJacqueline S Garcia, Shruti Bhatt, Geoffrey Fell, et al.
Pageof 33